• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌中肌酸转运蛋白 SLC6A8 的上调和表观遗传修饰。

Upregulation and epigenetic modification of the creatine transporter SLC6A8 in non-small cell lung cancer.

机构信息

Institute of Pathology, University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.

Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Großhansdorf, Germany.

出版信息

Histol Histopathol. 2024 Jul;39(7):867-876. doi: 10.14670/HH-18-731. Epub 2024 Mar 7.

DOI:10.14670/HH-18-731
PMID:38529720
Abstract

INTRODUCTION

Lung cancer is a major cause of cancer-related death worldwide and effective therapies, besides surgery, are available only for a small proportion of patients. Since cellular respiration is known to be broadly altered in malignant tumors, the cellular processes of respiration can be a potential therapeutic target. One important element of cellular respiration is creatine and its transport by the creatine transporter SLC6A8. Here we describe the expression of SLC6A8 at the RNA and protein level, epigenetic modifications as well as survival analysis in NSCLC tissues and matched controls.

MATERIALS AND METHODS

We analyzed epigenetic modifications of the gene in 32 patients, of which 18 were additionally analyzed by transcriptome analysis. The expression of SLC6A8 at the protein level was assessed by immunohistochemistry using an independent cohort and correlated with clinicopathological data including survival. Kaplan-Meier analysis was performed to analyze the possible effects of the transcriptional levels of in another separate cohort (n=1925).

RESULTS

loci are epigenetically modified in NSCLC compared with tumor-free controls. SLC6A8 is upregulated in NSCLC at the RNA and protein level. High mRNA expression of was associated with an overall poor prognosis in lung adenocarcinoma patients and displayed the strongest adverse prognostic effect in male smokers with adenocarcinomas. Results of transcriptome analysis were partially confirmed at the protein level.

CONCLUSIONS

Our results suggest an important role of creatine and its transport via SLC6A8 in NSCLC.

摘要

简介

肺癌是全球癌症相关死亡的主要原因,除了手术之外,有效的治疗方法仅适用于一小部分患者。由于已知恶性肿瘤中细胞呼吸广泛改变,因此细胞呼吸过程可能是潜在的治疗靶点。细胞呼吸的一个重要元素是肌酸及其由肌酸转运蛋白 SLC6A8 转运。在这里,我们描述了 SLC6A8 在非小细胞肺癌组织和匹配对照中的 RNA 和蛋白质水平的表达、表观遗传修饰以及生存分析。

材料和方法

我们分析了 32 名患者中 基因的表观遗传修饰,其中 18 名患者还通过转录组分析进行了分析。使用独立队列通过免疫组织化学评估 SLC6A8 在蛋白质水平的表达,并与包括生存在内的临床病理数据相关联。Kaplan-Meier 分析用于分析另一个独立队列(n=1925)中 的转录水平的可能影响。

结果

与无肿瘤对照相比, 基因在非小细胞肺癌中存在表观遗传修饰。SLC6A8 在非小细胞肺癌中在 RNA 和蛋白质水平上均上调。高 表达与肺腺癌患者的总体预后不良相关,并且在患有腺癌的男性吸烟者中显示出最强的不利预后影响。蛋白质水平的转录组分析结果部分得到证实。

结论

我们的结果表明肌酸及其通过 SLC6A8 在非小细胞肺癌中的转运具有重要作用。

相似文献

1
Upregulation and epigenetic modification of the creatine transporter SLC6A8 in non-small cell lung cancer.非小细胞肺癌中肌酸转运蛋白 SLC6A8 的上调和表观遗传修饰。
Histol Histopathol. 2024 Jul;39(7):867-876. doi: 10.14670/HH-18-731. Epub 2024 Mar 7.
2
SLC6A8-mediated intracellular creatine accumulation enhances hypoxic breast cancer cell survival via ameliorating oxidative stress.SLC6A8 介导的细胞内肌酸积累通过改善氧化应激增强缺氧乳腺癌细胞的存活。
J Exp Clin Cancer Res. 2021 May 14;40(1):168. doi: 10.1186/s13046-021-01933-7.
3
Mitochondrial Pyruvate Carrier 1 as a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer.线粒体丙酮酸载体 1 作为非小细胞肺癌的新型预后生物标志物。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241282080. doi: 10.1177/15330338241282080.
4
Functional and electrophysiological characterization of four non-truncating mutations responsible for creatine transporter (SLC6A8) deficiency syndrome.负责肌酸转运蛋白(SLC6A8)缺乏综合征的四个非截断突变的功能和电生理学特征。
J Inherit Metab Dis. 2013 Jan;36(1):103-12. doi: 10.1007/s10545-012-9495-9. Epub 2012 May 30.
5
Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.Cripto-1的高表达与非小细胞肺癌的不良预后相关。
Tumour Biol. 2014 Sep;35(9):8673-8. doi: 10.1007/s13277-014-2039-1. Epub 2014 May 29.
6
SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.SATB1水平与Ki-67表达相关,是非小细胞肺癌的一个阳性预后因素。
Anticancer Res. 2018 Feb;38(2):723-736. doi: 10.21873/anticanres.12278.
7
Upregulation of the creatine transporter Slc6A8 by Klotho.α-klotho对肌酸转运蛋白Slc6A8的上调作用。
Kidney Blood Press Res. 2014;39(6):516-25. doi: 10.1159/000368462. Epub 2014 Nov 29.
8
Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.DEK过表达对非小细胞肺癌预后评估的意义
Oncol Rep. 2016 Jan;35(1):155-62. doi: 10.3892/or.2015.4365. Epub 2015 Oct 30.
9
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.SIX3 的下调与肺腺癌的临床结果相关。
PLoS One. 2013 Aug 16;8(8):e71816. doi: 10.1371/journal.pone.0071816. eCollection 2013.
10
Overexpression of wild-type creatine transporter (SLC6A8) restores creatine uptake in primary SLC6A8-deficient fibroblasts.野生型肌酸转运蛋白(SLC6A8)的过表达可恢复原发性SLC6A8缺陷型成纤维细胞中的肌酸摄取。
J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):345-6. doi: 10.1007/s10545-006-0271-6.

本文引用的文献

1
is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma.是肺腺癌预后不良的潜在生物标志物。
Front Genet. 2022 May 27;13:845373. doi: 10.3389/fgene.2022.845373. eCollection 2022.
2
SLC6A8 is involved in the progression of non-small cell lung cancer through the Notch signaling pathway.溶质载体家族6成员8(SLC6A8)通过Notch信号通路参与非小细胞肺癌的进展。
Ann Transl Med. 2021 Feb;9(3):264. doi: 10.21037/atm-20-5984.
3
Creatine metabolism: energy homeostasis, immunity and cancer biology.肌酸代谢:能量平衡、免疫和癌症生物学。
Nat Rev Endocrinol. 2020 Aug;16(8):421-436. doi: 10.1038/s41574-020-0365-5. Epub 2020 Jun 3.
4
Creatine uptake regulates CD8 T cell antitumor immunity.肌酸摄取调节 CD8 T 细胞抗肿瘤免疫。
J Exp Med. 2019 Dec 2;216(12):2869-2882. doi: 10.1084/jem.20182044. Epub 2019 Oct 18.
5
Slc6a8-Mediated Creatine Uptake and Accumulation Reprogram Macrophage Polarization via Regulating Cytokine Responses.Slc6a8 介导的肌酸摄取和积累通过调节细胞因子反应重编程巨噬细胞极化。
Immunity. 2019 Aug 20;51(2):272-284.e7. doi: 10.1016/j.immuni.2019.06.007. Epub 2019 Aug 6.
6
Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapy.肿瘤突变负荷在接受免疫治疗的非小细胞肺癌患者中的临床应用价值
Transl Lung Cancer Res. 2018 Dec;7(6):647-660. doi: 10.21037/tlcr.2018.09.22.
7
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.现行世卫组织指南与免疫组织化学标志物在非小细胞肺癌(NSCLC)分类中的关键作用:从靶向治疗到免疫治疗。
Semin Cancer Biol. 2018 Oct;52(Pt 1):103-109. doi: 10.1016/j.semcancer.2017.11.019. Epub 2017 Nov 26.
8
Non-coding RNA networks in cancer.癌症中的非编码RNA网络
Nat Rev Cancer. 2018 Jan;18(1):5-18. doi: 10.1038/nrc.2017.99. Epub 2017 Nov 24.
9
Variability of Creatine Metabolism Genes in Children with Autism Spectrum Disorder.自闭症谱系障碍儿童中肌酸代谢基因的变异性
Int J Mol Sci. 2017 Jul 31;18(8):1665. doi: 10.3390/ijms18081665.
10
Epigenetic modifications of the immune-checkpoint genes and in non-small cell lung cancer results in increased expression.免疫检查点基因的表观遗传修饰与非小细胞肺癌中基因表达增加有关。
Clin Epigenetics. 2017 May 11;9:51. doi: 10.1186/s13148-017-0354-2. eCollection 2017.